Evotec is a fast-growing, global, high-quality provider in the drug discovery field and has a 20-year corporate history. Founded in 1993, the Company has built substantial drug discovery expertise and deep internal knowledge in the fields of metabolic diseases, neuroscience, pain, inflammation and oncology. By leveraging these skills and expertise, the company intends to develop best-in-class differentiated  therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Headquartered in Hamburg, Germany, the Evotec Group operates worldwide with subsidiaries in Germany, UK and USA.

Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. Evotec operates worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic.